Brisbane, Australia-based Oventus Medical has developed a medical device to reduce or eliminate snoring and obstructive sleep apnea.
The O2Vent is a 3D-printed titanium jaw advancement device custom fitted to a patient's mouth. The device contains a separate airway that directs air to the back of the mouth, bypassing obstructions in the nose, back of mouth and tongue.
In a recent clinical study of the O2Vent, the device eliminated snoring in 82 percent of patients and significantly reduced snoring in 100 percent of patients. Positive results were seen in people who had nasal obstructions and mainly breathed through their mouths.
"The recent clinical trial data strongly showed that the O2Vent significantly reduced snoring and sleep apnea in most patients studied, even in those who historically did not benefit from other treatments due to chronic nasal obstruction. The trial also demonstrated that the device improves oxygen levels in most patients," said Chris Hart, MD, Oventus' founder and clinical director.
The device received clearance from the FDA in March and will be available for sale in the US later this year.
More articles on supply chain:
New device eliminates fear, pain from blood tests
FDA approves new insomnia device
FDA rejects record number of drug applications: 5 main takeaways